Presentation TCT 2017 Representation of Women and Minorities in European Trials Presenter: David P. Faxon, Cindy L. Grines, Angeles Alonso Garcia October 31, 2017
Presentation TCT 2017 Strategies to Increase Enrollment of Women and Minorities Into Clinical Trials Presenter: David P. Faxon, Cindy L. Grines, Roxana Mehran October 31, 2017
Presentation TCT 2017 FDA Perspectives on Diversity in Clinical Trials Presenter: David P. Faxon, Cindy L. Grines, Christopher J Popma October 31, 2017
Presentation TCT 2017 Musings on TMVR Patient Selection Criteria to Date, and Which Patients Should Be Put in TMVR Trials Rather Than Treated Clinically With Current Devices Presenter: Howard C. Herrmann, Michael J. Mack October 31, 2017
Presentation TCT 2017 FDA Perspectives on Short DAPT IDE Trials Presenter: Mitchell W. Krucoff, P.F. Adrian Magee October 31, 2017
Presentation TCT 2017 TCT 51: Impact of Anticoagulation Therapy on Valve Hemodynamics and Clinical Outcomes After Bioprosthetic Aortic Valve Replacement: A Pooled Analysis of the PARTNER2 Trials Presenter: Peter C. Block, Lars Sondergaard, Tarun Chakravarty, MD October 31, 2017
Presentation TCT 2017 ABSORB 3-Year Meta-analysis: 3-Year Outcomes of a Bioresorbable Scaffold Compared to a Metallic DES From an Individual Patient Data Meta-analysis of Four Randomized Trials Presenter: David P. Faxon, Joseph A. Hill, Ziad A. Ali October 31, 2017
Presentation TCT 2017 PARTNER 2A and SAPIEN 3 Cost-effectiveness: Cost-effectiveness of TAVR vs SAVR in Intermediate-Risk Patients With Aortic Stenosis Presenter: Patrick W. Serruys, David J. Cohen October 31, 2017
Presentation TCT 2017 ABSORB IV: 30-Day Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease Presenter: Patrick W. Serruys, Gregg W. Stone October 31, 2017
Presentation TCT 2017 ABSORB III: 3-Year Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease Presenter: Patrick W. Serruys, Stephen G. Ellis October 31, 2017
Presentation TCT 2017 Featured Lecture: The NIH Mission to Enhance DIVERSITY in Clinical Trials, Education, and the Workforce Presenter: Roxana Mehran, George A. Mensah October 31, 2017
Presentation TCT 2017 Perspectives on the Feasibiity and Trustworthiness of Large, Simple Trials: From TASTE to ADAPTABLE Presenter: Robert A. Harrington, Sanjay Kaul, Schuyler Jones October 30, 2017
Presentation TCT 2017 Natures Randomized Trials: Natural Experiments, Instrumental Variables, and Mendelian Randomization (Strengths and Limitations) Presenter: Robert A. Harrington, Sanjay Kaul, Robert W. Yeh October 30, 2017
Presentation TCT 2017 Amulet: Data Synthesis and Ongoing Trials Presenter: William A. Gray, Vivek Y. Reddy, Fabian Nietlispach October 30, 2017
Presentation TCT 2017 Clinical Trials Using RAPID: Some POC Thoughts Presenter: Schuyler Jones, Hiroyoshi Yokoi, Theodore Heise October 30, 2017
Presentation TCT 2017 WATCHMAN: Data Synthesis and Ongoing Trials Presenter: William A. Gray, Vivek Y. Reddy October 30, 2017
Presentation TCT 2017 Do the PIONEER and RE-DUAL Results Alter LAA Closure Decisions? Presenter: William A. Gray, Vivek Y. Reddy, C. Michael Gibson October 30, 2017
Presentation TCT 2017 Perspectives on Current Trials in Renal Denervation: Evolution of Design, Endpoints, and Objectives Presenter: Michael Böhm, Thomas F. Luscher, Felix Mahfoud October 30, 2017
Presentation TCT 2017 Should the Improved Results With NOACs Compared to Warfarin Change LAA Closure Decisions? Presenter: William A. Gray, Vivek Y. Reddy, Kurt Huber October 30, 2017
Presentation TCT 2017 Diversity in Clinical Trials (Lessons Learned, Future Directions): Inclusion of Women Presenter: Wayne B. Batchelor, George A. Mensah, Roxana Mehran October 30, 2017